Prospective evaluation of AMACR (P504S) and basal cell markers in the assessment of routine prostate needle biopsy specimens
- 18 December 2004
- journal article
- Published by Elsevier in Human Pathology
- Vol. 35 (12) , 1462-1468
- https://doi.org/10.1016/j.humpath.2004.09.009
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Basal Cell Cocktail (34βE12 + p63) Improves the Detection of Prostate Basal CellsThe American Journal of Surgical Pathology, 2003
- P504S/α-Methylacyl-CoA RacemaseThe American Journal of Surgical Pathology, 2002
- Comparison of the Basal Cell-Specific Markers, 34βE12 and p63, in the Diagnosis of Prostate CancerThe American Journal of Surgical Pathology, 2002
- Alpha-Methylacyl-CoA RacemaseThe American Journal of Surgical Pathology, 2002
- α-Methylacyl Coenzyme A Racemase as a Tissue Biomarker for Prostate CancerJAMA, 2002
- P504SThe American Journal of Surgical Pathology, 2001
- Incidence of prostate cancer diagnosis in the eras before and after serum prostate-specific antigen testingPublished by American Medical Association (AMA) ,1995
- The Utility of Basal Cell—Specific Anti-Cytokeratin Antibody (34βE12) in the Diagnosis of Prostate CancerThe American Journal of Surgical Pathology, 1995
- Comparison of Digital Rectal Examination and Serum Prostate Specific Antigen in the Early Detection of Prostate Cancer: Results of a Multicenter Clinical Trial of 6,630 MenJournal of Urology, 1994
- Atypical adenomatous hyperplasia of the prostate: Morphologic criteria for its distinction from well-differentiated carcinomaHuman Pathology, 1993